Xencor, Inc. (XNCR)
24.63
+0.13
(+0.53%)
USD |
NASDAQ |
Oct 09, 16:00
24.59
-0.04
(-0.16%)
After-Hours: 20:00
Xencor Cash from Operations (Quarterly) : -55.66M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.66M |
| March 31, 2026 | -67.63M |
| December 31, 2025 | -51.71M |
| September 30, 2025 | -30.82M |
| June 30, 2025 | -36.37M |
| March 31, 2025 | -16.22M |
| December 31, 2024 | -49.84M |
| September 30, 2024 | -26.02M |
| June 30, 2024 | -65.34M |
| March 31, 2024 | -55.26M |
| December 31, 2023 | 181.21M |
| September 30, 2023 | -27.28M |
| June 30, 2023 | -38.20M |
| March 31, 2023 | -30.61M |
| December 31, 2022 | -24.43M |
| September 30, 2022 | -1.168M |
| June 30, 2022 | 44.27M |
| March 31, 2022 | 5.815M |
| December 31, 2021 | 61.79M |
| September 30, 2021 | -39.02M |
| June 30, 2021 | -9.654M |
| March 31, 2021 | -29.97M |
| December 31, 2020 | 17.08M |
| September 30, 2020 | -3.866M |
| June 30, 2020 | -27.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.46M |
| December 31, 2019 | -19.58M |
| September 30, 2019 | -6.477M |
| June 30, 2019 | 109.16M |
| March 31, 2019 | -18.73M |
| December 31, 2018 | -16.78M |
| September 30, 2018 | -10.31M |
| June 30, 2018 | -28.42M |
| March 31, 2018 | -24.24M |
| December 31, 2017 | -6.666M |
| September 30, 2017 | -3.509M |
| June 30, 2017 | -12.88M |
| March 31, 2017 | -10.55M |
| December 31, 2016 | -15.79M |
| September 30, 2016 | 134.07M |
| June 30, 2016 | -9.369M |
| March 31, 2016 | -14.30M |
| December 31, 2015 | -3.845M |
| September 30, 2015 | 39.52M |
| June 30, 2015 | -6.916M |
| March 31, 2015 | -2.093M |
| December 31, 2014 | -5.864M |
| September 30, 2014 | -4.72M |
| June 30, 2014 | -5.774M |
| March 31, 2014 | -4.993M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| UroGen Pharma Ltd. | -35.02M |
| MeiraGTx Holdings Plc | -38.54M |
| IDEAYA Biosciences, Inc. | -88.21M |
| Iovance Biotherapeutics, Inc. | -60.84M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 85.12M |
| Cash from Financing (Quarterly) | 1.031M |
| Free Cash Flow | -208.28M |
| Free Cash Flow Per Share (Quarterly) | -0.7408 |
| Free Cash Flow to Equity (Quarterly) | -51.14M |
| Free Cash Flow to Firm (Quarterly) | -48.91M |
| Free Cash Flow Yield | -11.27% |